Upon the end of the COVID-19 Public Health Emergency, the Health Resources & Services Administration (HRSA) will end a 2020 policy allowing hospitals to use 340B drugs for eligible patients in new hospital locations, even if they have not yet appeared on a filed Medicare cost report. Beginning May 11, 2023, at 11:59 PM ET, the hospital should stop purchasing and using 340B drugs for that outpatient facility that is not yet registered. More information can be found on the HRSA COVID-19 resources website. Members with questions may contact Elizabeth Kutter at the MHA.
The MHA is hosting the webinar MHA Programs of All-Inclusive Care for the Elderly (PACE): An Alternative to Traditional Nursing Home care from 8:30 to 9:30 a.m. May 23. Participants will learn about PACE philosophies, services provided, structure and financing and how health systems can partner with local PACE programs to support and enhance senior care. There is no cost to attend and members can register online.
Completed 2022 occupational mix surveys must be submitted by acute care hospitals paid under the Medicare prospective payment system to the Medicare Administrative Contractor by June 30, 2023. Hospitals are required to complete the survey every three years, with results from the 2022 survey to be used to adjust the Medicare wage index for fiscal years 2025, 2026 and 2027. Hospitals are encouraged to review their 2019 survey and determine whether there have been payroll changes, new job codes or job descriptions added, etc., to streamline the completion process. It is important to note that contact labor should be included in the various categories of the survey. Resource materials from the educational webinar hosted by the MHA in late January are available upon request. Members with questions should contact Vickie Kunz at the MHA.